Evaluating the Feasibility and Reliability of Remotely Delivering and Scoring the North Star Ambulatory Assessment in Ambulant Patients with Duchenne Muscular Dystrophy

被引:4
|
作者
Emery, Nicholas [1 ]
Strachan, Kate [1 ]
Kulshrestha, Richa [1 ]
Kuiper, Jan Herman [1 ,2 ]
Willis, Tracey [1 ]
机构
[1] Robert Jones & Agnes Hunt Orthopaed Hop, Neuromuscular Serv, TORCH Bldg, Oswestry SY10 7AG, Shrops, England
[2] Keele Univ, Sch Pharm & Bioengn, Keele ST5 5BG, Staffs, England
来源
CHILDREN-BASEL | 2022年 / 9卷 / 05期
关键词
Duchenne muscular dystrophy; north star ambulatory assessment; video assessment; MISSING DATA; SAMPLE-SIZE;
D O I
10.3390/children9050728
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objective: The North Star Ambulatory Assessment (NSAA) is a validated 17-item functional rating scale and widely used to assess motor function in boys with Duchenne muscular dystrophy (DMD). The SARS-CoV-2 pandemic and subsequent Government 'lockdown' resulted in no face-toface clinic visits hence the motor abilities were not monitored. The aim was to investigate whether the NSAA was feasible and reliable by video assessment. Method: Ten ambulant DMD boys were selected from the electronic hospital records. Two physiotherapists scored the boys' NSAA independently and the intraclass correlation coefficient was used to assess agreement. The video scores were compared to two previous NSAA in-clinic scores. Results: Mean scores (SD) for clinic visit one were 22.6 (4.19) and clinic visit two 21.8 (5.3). The two physiotherapists video mean scores were 20.6 (5.66) for physiotherapist 1 and 20.6 (6.53) for physiotherapist 2. The intraclass correlation coefficient was 0.98 (95% CI 0.93-1.00) for the total NSAA and 1.00 (95% CI 1.00 to 1.00) for the rise time. The mean decline in score from clinic visit one (-12 months) to video assessment was 2.0 (2.8 SD). Conclusion: The results from the study suggest that video NSAA is partially feasible and reliable.
引用
收藏
页数:10
相关论文
共 44 条
  • [21] Steroids in Duchenne muscular dystrophy (DMD): Natural history and clinical evaluation using the North Star Ambulatory Assessment (NSAA)
    Eagle, M.
    Scott, E.
    Main, M.
    Sheehan, J.
    Michelle, M.
    Guglieri, M.
    Straub, V.
    Bushby, K.
    [J]. NEUROMUSCULAR DISORDERS, 2007, 17 (9-10) : 774 - 774
  • [22] Hypermobility in young boys with Duchenne muscular dystrophy and its effect on attainment of North Star Ambulatory Assessment functional skills
    Abbott, L.
    Selby, V.
    Gupta, V. Ayyar
    Wadsworth, S.
    Wolfe, A.
    Chesshyre, M.
    Baranello, G.
    Scoto, M.
    Manzur, A.
    Main, M.
    Muntoni, F.
    [J]. NEUROMUSCULAR DISORDERS, 2020, 30 : S64 - S65
  • [23] Centiles by age for the North Star ambulatory assessment and the associated timed items in glucocorticoid treated boys with Duchenne muscular dystrophy
    Stimpson, G.
    Ridout, D.
    Wolfe, A.
    Milev, E.
    O'Reilly, E.
    Manzur, A.
    Cole, T.
    Muntoni, F.
    Baranello, G.
    [J]. NEUROMUSCULAR DISORDERS, 2023, 33 : S83 - S83
  • [24] Correlation and validation of the North Star Ambulatory Assessment, timed test and motor function measure centiles for boys with Duchenne muscular dystrophy
    Milev, E.
    Stimpson, G.
    van der Holst, M.
    Wolfe, A.
    O'Reilly, E.
    Manzur, A.
    Niks, E.
    Houwen-Opstal, S.
    Baranello, G.
    Muntoni, F.
    [J]. NEUROMUSCULAR DISORDERS, 2023, 33 : S82 - S82
  • [25] Validity and Reliability of Quick Motor Function Test in Ambulatory Duchenne Muscular Dystrophy Patients
    Imamoglu, Sena
    Kenis-Coskun, Ozge
    Deveci, Mehmet
    Ozturk, Gulten
    Karadag-Saygi, Evrim
    [J]. JOURNAL OF PEDIATRIC NEUROLOGY, 2022, 20 (06) : 380 - 385
  • [26] Longitudinal reliability of clinical outcome measures and quantitative muscle MRI in ambulant patients with Duchenne muscular dystrophy
    Nagy, S.
    Schadelin, S.
    Hafner, P.
    Bonati, U.
    Schmidt, S.
    Orsini, A. -L.
    Bieri, O.
    Fischer, D.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 324 - 324
  • [27] Preservation of function over time as measured by North Star ambulatory assessment in boys with nonsense mutation Duchenne muscular dystrophy treated with ataluren
    McDonald, C.
    Wei, L.
    Jin, F.
    Elfring, G.
    Trifillis, P.
    Souza, M.
    McIntosh, J.
    Peltz, S.
    Muntoni, F.
    [J]. NEUROMUSCULAR DISORDERS, 2018, 28 : S62 - S63
  • [28] Novel approaches to analysis of the North Star Ambulatory Assessment (NSAA) in Duchenne muscular dystrophy (DMD): Observations from a phase 2 trial
    Muntoni, Francesco
    Guglieri, Michela
    Mah, Jean K.
    Wagner, Kathryn R.
    Brandsema, John F.
    Butterfield, Russell J.
    McDonald, Craig M.
    Mayhew, Anna G.
    Palmer, Jeffrey P.
    Marraffino, Shannon
    Charnas, Lawrence
    Mercuri, Eugenio
    [J]. PLOS ONE, 2022, 17 (08):
  • [29] Predicting long-term trajectories of the North Star Ambulatory Assessment (NSAA) total score in Duchenne muscular dystrophy (DMD): an updated model
    Muntoni, F.
    Signorovitch, J.
    Goemans, N.
    Manzur, A.
    Done, N.
    Sajeev, G.
    Li, J.
    Akbarnejad, H.
    Sharma, A.
    Niks, E.
    Servais, L.
    Straub, V.
    de Groot, I.
    Ward, S.
    McDonald, C.
    [J]. NEUROMUSCULAR DISORDERS, 2023, 33 : S82 - S82
  • [30] Trial readiness: Clinical interpretability of change scores of the North Star Ambulatory Assessment in Duchenne muscular dystropy
    Mayhew, A. G.
    Eagle, M.
    Scott, E.
    Bushby, K. M. D.
    Adnan, M.
    Muntoni, F.
    Cano, S. J.
    [J]. NEUROMUSCULAR DISORDERS, 2012, 22 (9-10) : 876 - 877